ArticleClinical and experimental hepatology2022

The TM6SF2 variant as a risk factor for hepatocellular carcinoma development in chronic liver disease patients.

Gamal Y S Raia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.